36 results about "Cutaneous inflammation" patented technology

The present invention relates to a composition having enhanced anti-inflammatory properties and to a method for inhibiting inflammation in biological tissue, including but not limited to skin. Skin inflammation includes any undesirable effect produced in or on the surface of skin, including but not limited to irritation, redness, swelling, local temperature elevation, fissures, desquamation, itch, pain, sensitivity, abrasion, discoloration, and bleeding or the like, and combinations thereof. The invention demonstrates that certain plant fractions, such as the serum fractions of Camellia sinensis (Recentia® CS), Citrus limon (Recentia® CL), and Trifolium pratense (Recentia® TP), can be effectively utilized in various products to inhibit inflammation of biological tissue, including but not limited to skin. In one embodiment, said plant fractions have not undergone any significant fermentation.

Disclosed are methods of treating pain in a mammal, which may include the step of administering human growth hormone to a mammal in need thereof. The pain treated by the disclosed methods may be of a type caused by inflammation induced mechanical and / or thermal hypersensitivity, and may include, for example, a pain type resulting from one or more conditions selected from peripheral injury pain, post-operative pain, cutaneous inflammation, cutaneous incision, muscle incision, or chronic pain. Disease states in which the disclosed methods may be used include fibromyalgia, sickle cell anemia, epidermolysis bullosa, erythromelalgia, complex regional pain syndrome, or generalized muscle pain.

Methods for treating cutaneous inflammation, are described. Also described is a method for inhibiting the mucous release into airways of a patient, methods for blocking IgE activation and for stabilizing the cell membrane of lymphocytes, mast cells, basophils, macrophages, monocytes, eosinophils, neutrophils, and the like, thereby preventing their further involvement in the increased inflammatory response to an IgE antigen challenge, and a method for inhibiting the migration of T-cells. Such methods involve administering to said patient a therapeutically effective amount of a peptide having the formula f-Met-Leu-X, wherein X is selected from the group consisting of Tyr, Tyr-Phe, Phe-Phe and Phe-Tyr.

The invention belongs to the field of daily chemical industry, especially relates to a daily skin care product and particularly relates to a multi-effect moisturizing and softening composition which can be used for regularizing skin, maintaining the water balance of skin, curing inflamed skin and erythema phenomena, prompting skin regeneration, refreshing and the like. The multi-effect moisturizing and softening composition comprises the following ingredients: oat glucan, bean collagen, aloe extract, microcapsule-coated ultraviolet absorbent, phytosterols, hydrogenated rosin glycerin ester, jojoba oil, natural squalane, siloxane, a natural an emulsifier, a water-phase thickener, a chelating agent, Ethylhexylglycerin, pentylene glycol, phenoxyethanol and water. The invention designs a temperate and multi-effect and high plant-content multi-effect moisturizing and softening composition through reasonably using and matching all ingredients. The multi-effect moisturizing and softening composition mainly aims at erythema, inflammation, crack, scratch and other problems, has the effects of moisturizing, softening, moisturizing, prompting skin regeneration, refreshing and the like, thus being an necessary daily caring and traveling skincare product.

Disclosed are methods of treating pain in a mammal, which may include the step of administering human growth hormone to a mammal in need thereof. The pain treated by the disclosed methods may be of a type caused by inflammation induced mechanical and / or thermal hypersensitivity, and may include, for example, a pain type resulting from one or more conditions selected from peripheral injury pain, post-operative pain, cutaneous inflammation, cutaneous incision, muscle incision, or chronic pain. Disease states in which the disclosed methods may be used include fibromyalgia, sickle cell anemia, epidermolysis bullosa, erythromelalgia, complex regional pain syndrome, or generalized muscle pain.

Methods for treating cutaneous inflammation, are described. Also described is a method for inhibiting the mucous release into airways of a patient, a method for blocking IgE activation of a lymphocyte, a method for stabilizing the cell membrane of a lymphocyte, thereby preventing their further involvement in the increased inflammatory response to an IgE antigen challenge, and a method for inhibiting the migration of T-cells. Such methods involve administering to said patient a therapeutically effective amount of a peptide having the formula f-Met-Leu-X, wherein X is selected from the group consisting of Tyr, Tyr-Phe, Phe-Phe and Phe-Tyr.

The invention relates to the technical field of cosmetics, and discloses a rhTSG6-FNIII1-C fusion protein, its application in skin care composition and its preparation method. The rhTSG6-FNⅢ1-C fusion protein is prepared by genetic engineering prokaryotic expression technology, and the specific method includes: codon optimization of the gene sequence of SEQ ID NO:1; construction of a recombinant expression vector and transformation; induction of recombinant Escherichia coli and expression; the expression product is separated and purified to prepare rhTSG6‑FNⅢ1‑C fusion protein. The skin care composition of the present invention has multiple dosage forms, such as aqueous solution, ointment, suppository, cream and facial mask, and has good skin care effects such as improving skin wrinkles and maintaining skin elasticity, reducing skin inflammation and allergy risks, and so on. It is used in the field of functional cosmetics or medical cosmetology.